Purdue Pharma spokesman Robert Josephson provided Marketplace with this statement in response to questions from The Uncertain Hour about OxyContin, the company, and its relationship with the FDA. The company’s responses are published in full below. Purdue Pharma L.P. Response December 12, 2017 1. Why did Purdue not do any clinical studies to back up the […]